Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 janv. 2024 05h27 HE | Source: Chr. Hansen Holding A/S

Completion of the combination between Novozymes and Chr. Hansen

January 29, 2024 – Company announcement no. 2 Please see attachment. CONTACT INFORMATION Investor Relations Tobias Cornelius Bjorklund +45 3077 8682...
26 janv. 2024 06h09 HE | Source: Chr. Hansen Holding A/S

All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

January 26, 2024 – Company announcement no. 1 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038...
20 déc. 2023 09h02 HE | Source: Chr. Hansen Holding A/S

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: South Korean merger approval granted

December 20, 2023 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press RelationsSanne Seyer-Hansen+45 6038...
19 déc. 2023 05h54 HE | Source: Chr. Hansen Holding A/S

Major shareholder announcement from Burlington Loan Management DAC

December 19, 2023 – Company announcement no. 12 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press...
12 déc. 2023 11h11 HE | Source: Chr. Hansen Holding A/S

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: Conditional competition clearance from the European Commission obtained

December 12, 2023 Please see attachment. Contact information Investor RelationsDisa Tuominen+45 6038 5826dkditu@chr-hansen.com Press RelationsSanne...
20 nov. 2023 02h03 HE | Source: Chr. Hansen Holding A/S

Update on the merger approval process for the combination of Novozymes and Chr. Hansen: The parties have submitted a remedy proposal to the European Commission.

November 20, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press RelationsSanne Seyer-Hansen+45 6038...
02 nov. 2023 08h10 HE | Source: Chr. Hansen Holding A/S

Managers' Transaction

November 2, 2023 - Announcement No. 11 Vesting of restricted share units Chr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below...
13 oct. 2023 09h16 HE | Source: Chr. Hansen Holding A/S

Managers' Transactions

October 13, 2023 - Announcement No. 10 Vesting of shares Chr. Hansen Holding A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below...
12 oct. 2023 02h02 HE | Source: Chr. Hansen Holding A/S

Chr. Hansen Holding A/S Interim Report Q4 2022/23

October 12, 2023 – Company announcement no. 9 Strong performance for the quarter despite a challenging environment Statement by CEO Mauricio Graber: “Supported by a strong Q4 performance, Chr....
10 oct. 2023 02h08 HE | Source: Chr. Hansen Holding A/S

Novozymes announce the Executive Leadership Team and organizational structure for the future combined company of Novozymes and Chr. Hansen

October 10, 2023 Please see attachment. Contact information Investor RelationsAnders Mohr Christensen+45 2515 2364dkamc@chr-hansen.com Press...

Page suivante